HG
INSIDER · NRIX · Nurix Therapeutics, Inc. · CHIEF SCIENTIFIC OFFICER
Hansen Gwenn
Every open-market transaction filed under this name, Sep 1 to Oct 15.
Filings
2
0 buys · 2 sells
Bought
—
open market, at cost
Sold
$73K
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 15 | NRIX | Nurix Therapeutics, Inc. | Chief Scientific Officer | Sell | 1,452 | $25.00 | $36K | +4.4% |
| Sep 1 | NRIX | Nurix Therapeutics, Inc. | Chief Scientific Officer | Sell | 1,452 | $25.47 | $37K | +2.5% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.